SGLT
-
Dapagliflozin (BMS512148)
Catalog No. A10285 SGLT2 抑制剂Dapagliflozin (BMS512148)抑制钠-葡萄糖转运蛋白(SGLT2)的亚型2,后者负责肾脏中至少90%的葡萄糖重吸收。 了解更多 -
Canagliflozin
Catalog No. A11100 SGLT2 抑制剂canagliflozin是2型亚钠葡萄糖转运蛋白(SGLT2)的抑制剂,作用于hSGLT2,无细胞试验中IC50为2.2 nM,比作用于hSGLT1选择性高413倍。 了解更多 -
Tofogliflozin
Catalog No. A12690 -
Remogliflozin
Catalog No. A13971 -
Ipragliflozin
Catalog No. A13556 -
Luseogliflozin
Catalog No. A13476 SGLT2 抑制剂Luseogliflozin是由Taisho Pharmaceutical开发的一种口服活性第二代钠葡萄糖共转运蛋白2(SGLT2)抑制剂,用于治疗2型糖尿病(T2DM)患者。 了解更多 -
T-1095
Catalog No. A15463 -
Canagliflozin hemihydrate
Catalog No. A16817 SGLT2 抑制剂Canagliflozin hemihydrate是半水形式的卡格列嗪,是一种SGLT2抑制剂,在无细胞检测中hSGLT2的IC50为2.2 nM,其选择性比hSGLT1高413倍。 了解更多 -
Ertugliflozin L-pyroglutamic acid
Catalog No. A18054 SGLT inhibitorErtugliflozin pidolate belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus. 了解更多 -
Dapagliflozin impurity
Catalog No. A19103 SGLT2 抑制剂Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor. 了解更多 -
Licogliflozin
Catalog No. A12828 SGLT1/SGLT2 抑制剂Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor. 了解更多